Literature DB >> 23621269

AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo.

Yun-Fei Ge1, Jun Sun, Chun-Jie Jin, Bo-Qiang Cao, Zhi-Feng Jiang, Jun-Fei Shao.   

Abstract

OBJECTIVE: To study the effect of the antagomiR-27a inhibitor on glioblastoma cells.
METHODS: The miR- 27a expression level in specimens of human glioblastoma and normal human brain tissues excised during decompression for traumatic brain injury was assessed using qRT-PCR; The predicted target gene of miR-27a was screened out through bioinformatics databases, and the predicted gene was verified using genetic report assays; the effect of antagomiR-27a on the invasion and proliferation of glioma cells was analyzed using MTT assays and 5-ethynyl-2'-deoxyuridine (EdU) labeling. A xenograft glioblastoma model in BALB-c nude mice was established to detect the effect of antagomiR-27a on tumour growth.
RESULTS: qRT-PCR results showed that miR-27a significantly increased in specimens from glioblastoma comparing with normal human brain tissues. Th miR-27a inhibitor significantly suppressed invasion and proliferation of glioblastoma cells. FOXO3a was verified as a new target of miR-27a by Western blotting and reporter analyzes. Tumor growth in vivo was suppressed by administration of the miR-27a inhibitor.
CONCLUSION: MiR-27a may be up-regulated in human glioblastoma, and antagomiR-27a could inhibit the proliferation and invasion ability of glioblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621269     DOI: 10.7314/apjcp.2013.14.2.963

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

Review 1.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

2.  MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value.

Authors:  Mónica Rivera-Díaz; Miguel A Miranda-Román; Daniel Soto; Mario Quintero-Aguilo; Humberto Ortiz-Zuazaga; María J Marcos-Martinez; Pablo E Vivas-Mejía
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Nicotine-induced miR-21-3p promotes chemoresistance in lung cancer by negatively regulating FOXO3a.

Authors:  Yong-Qing Zhang; Rui-Lin Chen; Li-Qun Shang; Shu-Mei Yang
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

Review 4.  Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Authors:  Roberto Gambari; Eleonora Brognara; Demetrios A Spandidos; Enrica Fabbri
Journal:  Int J Oncol       Date:  2016-05-04       Impact factor: 5.650

5.  A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.

Authors:  Antigny Fabrice; Ranchoux Benoît; Nadeau Valérie; Edmund Lau; Bonnet Sébastien; Perros Frédéric
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-09       Impact factor: 2.916

Review 6.  From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).

Authors:  Roberta Piva; Demetrios A Spandidos; Roberto Gambari
Journal:  Int J Oncol       Date:  2013-08-12       Impact factor: 5.650

Review 7.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

8.  MicroRNA-27a-mediated repression of cysteine-rich secretory protein 2 translation in asthenoteratozoospermic patients.

Authors:  Jun-Hao Zhou; Qi-Zhao Zhou; Jian-Kun Yang; Xiao-Ming Lyu; Jun Bian; Wen-Bin Guo; Zi-Jian Chen; Ming Xia; Hui Xia; Tao Qi; Xin Li; Cun-Dong Liu
Journal:  Asian J Androl       Date:  2017 Sep-Oct       Impact factor: 3.285

9.  MicroRNA-552 enhances metastatic capacity of colorectal cancer cells by targeting a disintegrin and metalloprotease 28.

Authors:  Jian Wang; Hai Li; Yong Wang; Libin Wang; Xiurui Yan; Dong Zhang; Xiaoqiang Ma; Yong Du; Xiaoming Liu; Yinxue Yang
Journal:  Oncotarget       Date:  2016-10-25

Review 10.  Critical role of FOXO3a in carcinogenesis.

Authors:  Ying Liu; Xiang Ao; Wei Ding; Murugavel Ponnusamy; Wei Wu; Xiaodan Hao; Wanpeng Yu; Yifei Wang; Peifeng Li; Jianxun Wang
Journal:  Mol Cancer       Date:  2018-07-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.